1. Home
  2. BOH vs ARQT Comparison

BOH vs ARQT Comparison

Compare BOH & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of Hawaii Corporation

BOH

Bank of Hawaii Corporation

HOLD

Current Price

$69.80

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.85

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOH
ARQT
Founded
1897
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
BOH
ARQT
Price
$69.80
$26.85
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
★ $85.40
$34.00
AVG Volume (30 Days)
330.6K
★ 2.4M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
★ 3.62%
N/A
EPS Growth
33.82
★ 88.79
EPS
★ 2.78
0.03
Revenue
$121,925,000.00
★ $376,072,000.00
Revenue This Year
$15.66
$34.85
Revenue Next Year
$7.82
$29.39
P/E Ratio
★ $25.33
$911.00
Revenue Growth
N/A
★ 91.34
52 Week Low
$59.36
$18.79
52 Week High
$86.31
$31.77

Technical Indicators

Market Signals
Indicator
BOH
ARQT
Relative Strength Index (RSI) 25.25 56.25
Support Level $67.04 $24.91
Resistance Level $79.80 $28.20
Average True Range (ATR) 1.48 1.45
MACD -0.35 0.30
Stochastic Oscillator 4.92 72.25

Price Performance

Historical Comparison
BOH
ARQT

About BOH Bank of Hawaii Corporation

Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: